TAI'AN CITY, Shandong, China, May 15 China Biologic Products, Inc. (OTC Bulletin Board: CBPO) (''CBP'', ''theCompany''), one of the leading plasma-based pharmaceutical companies in thePeople's Republic of China (''PRC''), today announced that it will conduct aconference call at 5:00 p.m. Eastern Time on Thursday, May 15, 2008 to discussthe first quarter 2008 results.
To participate in the live conference call, please dial the followingnumber five to ten minutes prior to the scheduled conference call time: 800688 0796. International callers should dial 617 614 4070. When prompted bythe operator, mention Conference Passcode 991 762 11.
If you are unable to participate in the call at this time, a replay willbe available for fourteen days starting on Thursday, May 15 at 7:00 p.m.Eastern Time. To access the replay, dial 888-286-8010, international callersshould dial 617-801-6888, and enter the passcode 533 752 43.
About China Biologic Products, Inc.
China Biologic Products, Inc., through its indirect majority-ownedsubsidiary Shandong Taibang, is currently the only plasma-basedbiopharmaceutical company approved by the government of Shandong Province, thesecond largest province with a population of 93 million. The company isengaged primarily in research, manufacturing, and sale of plasma-basedbiopharmaceutical products to hospitals and other health care facilities inChina. Plasma-based Human Albumin is used mainly to increase blood volumewhile Immunoglobulin is used for disease prevention and treatment.For more information, please contact: Company Contact: Mr. Stanley Wong CEO China Biologic Products, Inc. Tel: +86-538-620-2306 Email: IR@chinabiologic.com Web: http://www.chinabiologic.com Investor Relations Contact: Mr. Crocker Coulson President CCG Elite Investor Relations Tel: +1-646-213-1915 (NY office) Email: firstname.lastname@example.org Web: http://www.ccgelite.com
SOURCE China Biologic Products, Inc.